These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25407966)

  • 1. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
    Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
    BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
    Ke X; Yang YC; Hong SL
    Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.
    Cao Y; Yang L; Jiang W; Wang X; Liao W; Tan G; Liao Y; Qiu Y; Feng D; Tang F; Hou BL; Zhang L; Fu J; He F; Liu X; Jiang W; Yang T; Sun LQ
    Mol Ther; 2014 Feb; 22(2):371-377. PubMed ID: 24322331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.
    Yang L; Liu L; Xu Z; Liao W; Feng D; Dong X; Xu S; Xiao L; Lu J; Luo X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
    Oncotarget; 2015 Mar; 6(8):5804-17. PubMed ID: 25714020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative assessment of vasculature with DCE-MRI in nasopharyngeal carcinomas following radiotherapy and its value for efficacy evaluation].
    Liao W; Yang L; Jiang W; Sun L; Cao Y; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):954-9. PubMed ID: 26198942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
    Yang L; Xu Z; Liu L; Luo X; Lu J; Sun L; Cao Y
    Cancer Biol Ther; 2014 Jan; 15(1):61-8. PubMed ID: 24145206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV‑LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.
    Xu S; Bai J; Zhuan Z; Li B; Zhang Z; Wu X; Luo X; Yang L
    Oncol Rep; 2018 Jul; 40(1):377-384. PubMed ID: 29749553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
    Chang PY; Wu ZZ; Sun NK; Chao CC
    J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
    Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
    J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
    Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
    Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
    Yu X; Li F; Hu Y; Lu Q; Wang H
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
    Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
    BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
    Yang L; Lu Z; Ma X; Cao Y; Sun LQ
    Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells.
    Ma X; Xu Z; Yang L; Xiao L; Tang M; Lu J; Xu S; Tang Y; Wen X; Deng X; Sun L; Cao Y
    Int J Oncol; 2013 Nov; 43(5):1541-8. PubMed ID: 24042231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.